SAB Biotherapeutics Inc. (SABS)
NASDAQ: SABSHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
After hours: 2.88 0.00%
SABS stock chart
Technical analysisKey statistics
All statistics- Market cap
- $262.04M
- EPS (TTM)
- -$1.29
- Dividend yield
- None
- 52-week range
- 2.10 – 5.15
- Day range
- 2.81 – 2.96
- Volume / Avg
- 679.31K / 495.86K
- Beta
- —
- Shares outstanding
- 90.99M
52-week range
SABS stock today
Shares of SAB Biotherapeutics (SABS) finished lower on Oct 7 at $2.88, a drop of 1.71% or $0.05 per share, versus the S&P 500's 0.22% decline. Shares are 44.1% below their 52-week high of $5.15, set on Mar 12, 2026 and 37.1% above the 52-week low of $2.10, in the middle of the past year's range. SABS is down 23.0% year to date, underperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has gained 23.1%.
SAB Biotherapeutics has posted a net loss over the last twelve months (EPS of -$1.29), so its P/E ratio is not meaningful.
Summary generated from market data by MetaCap's automated system. Methodology
About SAB Biotherapeutics
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
- IPO year
- 2021
SAB Biotherapeutics peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| IKTInhibikase Therapeutics Inc. | 1.94 | -2.02% | $270.70M | vs SABS |
| LXEOLexeo Therapeutics Inc. | 3.31 | +0.30% | $271.71M | vs SABS |
| PALIPalisade Bio Inc. | 1.48 | -0.67% | $257.92M | vs SABS |
| FATEFate Therapeutics Inc. | 2.15 | -6.11% | $257.61M | vs SABS |
| XFORX4 Pharmaceuticals Inc. | 2.81 | +1.44% | $278.60M | vs SABS |
| STROSutro Biopharma Inc. | 14.66 | +1.45% | $243.08M | vs SABS |
| LCTXLineage Cell Therapeutics Inc. | 0.9476 | +1.03% | $239.66M | vs SABS |
| SRZNSurrozen Inc. | 25.15 | -4.65% | $295.54M | vs SABS |
Indexes, lists and sector
Largest Health Care stocks
SAB Biotherapeutics stock FAQ
What is SAB Biotherapeutics's stock price today?
SABS last traded at $2.88 as of Oct 7, 4:00 PM EDT, down 1.71% on the day. Prices are delayed at least 15 minutes.
Does SAB Biotherapeutics pay a dividend?
No. SAB Biotherapeutics does not currently pay a regular cash dividend.
Has SABS ever split its stock?
Yes. The most recent SABS stock split was a 1-for-10 split on Jan 5, 2024.
What is the SABS 52-week high?
The 52-week high for SABS is $5.15 and the 52-week low is $2.10. The stock is currently 44.1% below its high.